chloroquine diphosphate has been researched along with Arrhythmias, Cardiac in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ehrlich, H; Elkbuli, A | 1 |
| Chudzik, M; Cygankiewicz, I; Sysa-Jedrzejowska, A; Wozniacka, A; Wranicz, JK | 1 |
| Deng, S; Duncan, JN; Dunne, M; Fossa, AA; Wisialowski, T | 1 |
3 other study(ies) available for chloroquine diphosphate and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Cardiac arrhythmias in COVID-19 patients: A combination of viral comorbidities and pro-arrhythmic drug interactions.
Topics: Angiotensin-Converting Enzyme 2; Anti-Bacterial Agents; Antimalarials; Arrhythmias, Cardiac; Azithromycin; Cardiovascular Diseases; Chloroquine; Comorbidity; COVID-19; COVID-19 Drug Treatment; Drug Interactions; Humans; Hydroxychloroquine; Long QT Syndrome; Myocytes, Cardiac; Receptors, Coronavirus; SARS-CoV-2; Torsades de Pointes | 2021 |
The cardiac safety of chloroquine phosphate treatment in patients with systemic lupus erythematosus: the influence on arrhythmia, heart rate variability and repolarization parameters.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antimalarials; Arrhythmias, Cardiac; Chloroquine; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Lupus Erythematosus, Systemic; Male; Membrane Potentials; Middle Aged | 2006 |
Azithromycin/chloroquine combination does not increase cardiac instability despite an increase in monophasic action potential duration in the anesthetized guinea pig.
Topics: Action Potentials; Anesthesia; Animals; Antimalarials; Arrhythmias, Cardiac; Azithromycin; Blood Pressure; Chloroquine; Dose-Response Relationship, Drug; Guinea Pigs; Heart; Heart Rate; Male | 2007 |